Subject(s)
Civil Defense , Drug Industry , Drugs, Essential , Health Planning/organization & administration , Strategic Stockpile , Surge Capacity , COVID-19/epidemiology , Civil Defense/methods , Civil Defense/organization & administration , Disaster Planning/organization & administration , Drug Industry/organization & administration , Drug Industry/standards , Drug Industry/statistics & numerical data , Drugs, Essential/classification , Drugs, Essential/economics , Drugs, Essential/supply & distribution , Humans , Legislation, Drug , Needs Assessment , SARS-CoV-2 , Strategic Stockpile/legislation & jurisprudence , Strategic Stockpile/organization & administration , Surge Capacity/legislation & jurisprudence , Surge Capacity/organization & administration , Surge Capacity/standards , United StatesABSTRACT
Coletiva de Imprensa OPAS COVID-19 31 de março de 2021 - áudio em Português.
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Immunization Programs/organization & administration , Viral Vaccines/supply & distribution , Epidemiological Monitoring , Americas/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Hospital Bed Capacity , Intensive Care Units , Betacoronavirus/genetics , Coronavirus Infections/genetics , Pneumonia, Viral/genetics , Mutation/genetics , DNA, Viral/genetics , Health Equity , Health Systems/organization & administration , Masks/supply & distribution , Strategic Stockpile/organization & administration , Social Isolation , Quarantine/organization & administrationABSTRACT
Sesión informativa para la prensa sobre la COVID-19 en las Américas - audio Español.
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Immunization Programs/organization & administration , Viral Vaccines/supply & distribution , Epidemiological Monitoring , Americas/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Hospital Bed Capacity , Intensive Care Units , Betacoronavirus/genetics , Coronavirus Infections/genetics , Pneumonia, Viral/genetics , Mutation/genetics , DNA, Viral/genetics , Health Equity , Health Systems/organization & administration , Masks/supply & distribution , Strategic Stockpile/organization & administration , Social Isolation , Quarantine/organization & administrationABSTRACT
PAHO press briefing on COVID-19 in the Americas - 03/31/2021 - audio em English.
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Immunization Programs/organization & administration , Viral Vaccines/supply & distribution , Epidemiological Monitoring , Americas/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Hospital Bed Capacity , Intensive Care Units , Betacoronavirus/genetics , Coronavirus Infections/genetics , Pneumonia, Viral/genetics , Mutation/genetics , DNA, Viral/genetics , Health Equity , Health Systems/organization & administration , Masks/supply & distribution , Strategic Stockpile/organization & administration , Social Isolation , Quarantine/organization & administrationABSTRACT
Conferencia de prensa de la OPS sobre COVID-19 / PAHO’s virtual press briefing on COVID-19 - audio original.
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Immunization Programs/organization & administration , Viral Vaccines/supply & distribution , Epidemiological Monitoring , Americas/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Hospital Bed Capacity , Intensive Care Units , Betacoronavirus/genetics , Coronavirus Infections/genetics , Pneumonia, Viral/genetics , Mutation/genetics , DNA, Viral/genetics , Health Equity , Health Systems/organization & administration , Masks/supply & distribution , Strategic Stockpile/organization & administration , Social Isolation , Quarantine/organization & administrationABSTRACT
PAHO press briefing on COVID-19 - 03/31/2021 - audio French
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Immunization Programs/organization & administration , Viral Vaccines/supply & distribution , Epidemiological Monitoring , Americas/epidemiology , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Hospital Bed Capacity , Intensive Care Units , Betacoronavirus/genetics , Coronavirus Infections/genetics , Pneumonia, Viral/genetics , Mutation/genetics , DNA, Viral/genetics , Health Equity , Health Systems/organization & administration , Masks/supply & distribution , Strategic Stockpile/organization & administration , Social Isolation , Quarantine/organization & administrationABSTRACT
O presidente do Conass, Carlos Lula, falou sobre a necessidade de atenção especial para os medicamentos do chamado kit intubação de pacientes e alertou para o risco da falta dessas medicações já nos próximos dias, repetindo o cenário ocorrido no segundo semestre de 2020.
Subject(s)
Coronavirus Infections/prevention & control , Pneumonia, Viral/prevention & control , Intubation/methods , Pandemics/prevention & control , Hypnotics and Sedatives/supply & distribution , Strategic Stockpile/organization & administrationABSTRACT
Os estados possuem estoque para iniciar a vacinação contra o novo coronavirus. Mas em campanhas de imunização não regulares, como é o caso da COVID-19, a compra de seringas e agulhas é de competência do Governo Federal.
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Strategic Stockpile/organization & administration , Viral Vaccines/supply & distributionABSTRACT
BACKGROUND: The disease caused by the novel coronavirus SARS-CoV-2 has rapidly spread escalating the situation to an international pandemic. The absence of a vaccine or an efficient treatment with enough scientific evidence against the virus has generated a healthcare crisis of great magnitude. The precautionary principle justifies the selection of the recommended medicines, whose demand has increased dramatically. METHODS: we carried out an analysis of the healthcare risk management and the main measures taken by the state healthcare authorities to a possible shortage of medicines in the most affected countries of the European Union: Spain, France, Italy and Germany. RESULTS: the healthcare risk management in the European Union countries is carried out based on the precautionary principle, as we do not have enough scientific evidence to recommend a specific treatment against the new virus. Some measures aimed to guarantee the access to medicines for the population has been adopted in the most affected countries by the novel coronavirus. CONCLUSIONS: in Spain, Italy and Germany, some rules based on the precautionary principle were pronounced in order to guarantee the supply of medicines, while in France, besides that, the competences of pharmacists in pharmacy offices have been extended to guarantee the access to medicines for the population.
Subject(s)
Antiviral Agents/supply & distribution , COVID-19 Drug Treatment , COVID-19 , Delivery of Health Care/trends , Health Services Accessibility , Risk Management , Strategic Stockpile/organization & administration , COVID-19/epidemiology , European Union , Health Services Accessibility/organization & administration , Health Services Accessibility/standards , Health Services Accessibility/statistics & numerical data , Humans , Quality Improvement/organization & administration , Quality Indicators, Health Care/organization & administration , Quality Indicators, Health Care/standards , Risk Management/methods , Risk Management/standards , SARS-CoV-2ABSTRACT
INTRODUCTION: globally, by 2020 the paralytic poliomyelitis disease burden decreased to over 99% of the reported cases in 1988 when resolution 41.8 was endorsed by the World Health Assembly (WHA) for global polio eradication. It is clearly understood that, if there is Wild Poliovirus (WPV) and circulating Vaccines Derived Poliovirus (cVDPV) in the world, no country is safe from polio outbreaks. All countries remain at high risk of re-importation depending on the level of the containment of the types vaccine withdrawn, the laboratory poliovirus isolates, and the population immunity induced by the vaccination program. In this regard, countries to have polio outbreak preparedness and response plans, and conducting the polio outbreak simulation exercises for these plans remain important. METHODS: we conducted a cross-section qualitative study to review to 8 countries conducted polio outbreak simulation exercises in the East and Southern Africa from 2016 to 2018. The findings were categorized into 5 outbreak response thematic areas analyzed qualitatively and summarized them on their strengths and weaknesses. RESULTS: we found out that, most countries have the overall technical capacities and expertise to deal with outbreaks to a certain extent. Nevertheless, we noted that the national polio outbreak preparedness and response plans were not comprehensive enough to provide proper guidance in responding to outbreaks. The guidelines were inadequately aligned with the WHO POSOPs, and IHR 2005. Additionally, most participants who participated in the simulation exercises were less familiar with their preparedness and response plans, the WHO POSOPs, and therefore reported to be sensitized. CONCLUSION: we also realized that, in all countries where the polio simulation exercise conducted, their national polio outbreak preparedness and response plan was revised to be improved in line with the WHO POSOPs and IHR 2005. we, therefore, recommend the polio outbreak simulation exercises to be done in every country with an interval of 3-5 years.
Subject(s)
Civil Defense/methods , Poliomyelitis/epidemiology , Poliomyelitis/therapy , Simulation Training/methods , Africa South of the Sahara/epidemiology , Civil Defense/organization & administration , Computer Simulation , Cross-Sectional Studies , Disease Eradication , Disease Outbreaks , Evaluation Studies as Topic , Global Health/standards , Health Plan Implementation/organization & administration , Health Plan Implementation/standards , History, 21st Century , Humans , Immunization Programs/methods , Immunization Programs/organization & administration , Immunization Programs/standards , National Health Programs/organization & administration , National Health Programs/standards , Poliovirus Vaccines/supply & distribution , Poliovirus Vaccines/therapeutic use , Population Surveillance , Retrospective Studies , Risk Assessment , Simulation Training/organization & administration , Simulation Training/standards , Strategic Stockpile/methods , Strategic Stockpile/organization & administrationABSTRACT
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pandemics/prevention & control , Pandemics/statistics & numerical data , Health Systems/organization & administration , Epidemiological Monitoring , Quarantine/organization & administration , Social Isolation , Personal Protective Equipment/supply & distribution , Healthcare Financing , Masks , Polymerase Chain Reaction/methods , Security Measures/organization & administration , Health Personnel/education , Health Human Resource Training , 50207 , Strategic Stockpile/organization & administration , Viral Vaccines/immunology , Viral Vaccines/supply & distribution , Dexamethasone/therapeutic use , Health CommunicationABSTRACT
Siga o Ministério da Saúde http://www.twitter.com/minsaude http://www.facebook.com/minsaude http://www.instagram.com/minsaude https://www.linkedin.com/company/mini...
Subject(s)
Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics/statistics & numerical data , Hospital Bed Capacity/statistics & numerical data , Intensive Care Units/statistics & numerical data , Financial Resources in Health/economics , Personal Protective Equipment/supply & distribution , Ventilators, Mechanical/supply & distribution , Local Health Systems/economics , Pandemics/economics , Brazil/epidemiology , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Polymerase Chain Reaction/statistics & numerical data , Public Health/economics , Federal Government , Strategic Stockpile/organization & administration , Viral Vaccines/supply & distribution , Access to Essential Medicines and Health Technologies , Epidemiological MonitoringABSTRACT
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio español
Subject(s)
Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics/statistics & numerical data , Quarantine/organization & administration , Epidemiological Monitoring , Vulnerable Populations , Risk Groups , Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Viral Vaccines/immunology , , Public Sector/economics , Commerce/organization & administration , Social Isolation , Social Protection in Health/policies , Hand Disinfection , Schools/standards , Travel-Related Illness , e-Government , Health Systems/organization & administration , Clinical Trial, Phase III , Viral Vaccines/adverse effects , Healthy Volunteers , Strategic Stockpile/organization & administration , Personal Protective Equipment/supply & distribution , Masks , Polymerase Chain ReactionABSTRACT
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio original
Subject(s)
Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics/statistics & numerical data , Quarantine/organization & administration , Epidemiological Monitoring , Vulnerable Populations , Risk Groups , Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Viral Vaccines/immunology , , Public Sector/economics , Commerce/organization & administration , Social Isolation , Social Protection in Health/policies , Hand Disinfection , Schools/standards , Travel-Related Illness , e-Government , Health Systems/organization & administration , Clinical Trial, Phase III , Viral Vaccines/adverse effects , Healthy Volunteers , Strategic Stockpile/organization & administration , Personal Protective Equipment/supply & distribution , Masks , Polymerase Chain ReactionABSTRACT
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio english
Subject(s)
Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics/statistics & numerical data , Quarantine/organization & administration , Epidemiological Monitoring , Vulnerable Populations , Risk Groups , Betacoronavirus/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Viral Vaccines/immunology , , Public Sector/economics , Commerce/organization & administration , Social Isolation , Social Protection in Health/policies , Hand Disinfection , Schools/standards , Travel-Related Illness , e-Government , Health Systems/organization & administration , Clinical Trial, Phase III , Viral Vaccines/adverse effects , Healthy Volunteers , Strategic Stockpile/organization & administration , Personal Protective Equipment/supply & distribution , Masks , Polymerase Chain ReactionABSTRACT
O Ministério da Saúde entregou ventiladores pulmonares e Equipamentos de Proteção Individual para auxílio no combate ao #coronavírus no Espírito Santo. A entrega faz parte da ação estratégica do Governo Federal em auxiliar os estados neste momento de pandemia. Saiba mais em saude.gov.br.
Subject(s)
Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics/statistics & numerical data , Ventilators, Mechanical/statistics & numerical data , Strategic Stockpile/organization & administration , Personal Protective Equipment/supply & distributionABSTRACT
União de forças para salvar vidas! Em um esforço interministerial, o Governo do Brasil comprou do Uruguai 54,8 mil unidades de medicamentos usados na intubação de pessoas que estão em estado grave na UTI, por conta de complicações da COVID-19. Esses remédios vão reforçar os estoques da região Sul do país. Já foram entregues 48.867 unidades de Propofol, 5 mil unidades de Priaxim e mil unidades dexmedetomidina. O Ministério da Saúde está atento às necessidades dos estados e municípios para atender as necessidades de assistência em saúde de quem mais precisa!
Subject(s)
Intubation , Strategic Stockpile/organization & administration , Propofol/supply & distribution , Uruguay , BrazilABSTRACT
#AoVivo - O ministro da Saúde Interino, Eduardo Pazuello, fala sobre ações de apoio a Santa Catarina no combate à #Covid19. Participam da coletiva a vice-governadora de SC, Daniela Reinehr, o secretário Estadual de Saúde André Motta Ribeiro e o prefeito de Florianópolis, Gean Marques Loureiro
Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/epidemiology , Coronavirus Infections/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/diagnosis , Pandemics/prevention & control , Quarantine/organization & administration , Social Isolation , Local Health Systems/organization & administration , Epidemiological Monitoring , Hospital Bed Capacity/statistics & numerical data , Intensive Care Units/statistics & numerical data , Hospitals/supply & distribution , Viral Vaccines/immunology , Coronavirus Infections/immunology , Pneumonia, Viral/immunology , Governmental Research Institutes , Clinical Trial, Phase III , Primary Health Care/organization & administration , Strategic Stockpile/organization & administration , Ventilators, Mechanical/supply & distribution , Local GovernmentABSTRACT
Com isso todos os 27 estados passam a ser co-participantes da ata nacional de registros de preço Diante da impossibilidade de aquisição dos medicamentos utilizados para intubação de pacientes com Covid-19, relatada por diversos estados desde o final de abril desse, decorrentes da escassez desses produtos no mercado nacional, o Ministério da Saúde anunciou uma série de medidas para apoiar as Secretarias Estaduais de Saúde (SES) na aquisição desses itens. Uma delas foi a abertura de processo de licitação na modalidade pregão, na forma eletrônica do tipo menor preço pelo Sistema de Registro de Preços (SRP). A medida teve a adesão de todas as Unidades da Federação, o que significa que elas passam a ser co-participantes da Ata Nacional de Registros de Preço. Com isso, todas as SES estão aptas a de fato, comprar dessa ata quando a mesma for publicada. “Fizemos um esforço inédito, em tempo recorde, na adesão da Ata de Compras dos medicamentos do kit de intubação. Nessa modalidade, temos um volume muito maior de insumos, barateando o preço final”, afirma o presidente do Conass, Carlos Lula. A importância, segundo observou Carlos Lula, é o ganho em escala, pois é uma estratégia que visa homogenizar o valor das aquisições dos medicamentos. “Os preços dos insumos foram equalizados para todos os estados, garantindo o aproveitamento dos recursos públicos”, ressaltou. O prazo para a adesão terminou ontem (13/7) e foi aberto um período de 48 horas para ajustes na intenção de juízo de preço por aquelas secretarias que assim desejarem. Passado esse período, o Ministério da Saúde irá publicar o edital para a licitação dos medicamentos, por meio de pregão eletrônico. Heber Dobis, assessor técnico do Conass, explica que por se tratar de uma ata de registro de preço, as SES não precisam necessariamente adquirir tudo em uma única compra, podendo comprar quantas vezes acharem necessário obedecendo ao limite do quantitativo registrado. “O preço estará registrado e a SES apenas fará o empenho de recursos e execução da aquisição conforme a sua necessidade”, pontuou. A responsabilidade pela distribuição dos medicamentos será do Ministério da Saúde que receberá o material em seu almoxarifado central em São Paulo e fará a logística para a entrega nos estados.
